Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Not applicable Interventional

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

ClinicalTrials.gov ID: NCT06245031

Public ClinicalTrials.gov record NCT06245031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Extension to a Randomized, Double-blind, Sham-controlled, Adaptive-Design Pivotal Study of Sensory Stimulation in Subjects With Alzheimer's Disease (OLE Hope Study, CA-0015)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study. Participants who complete the Hope Study (CA-0011) will be eligible to consent for screening to enroll in the OLE Hope Study (CA-0015). All participants will be treated with an Active Sensory Stimulation System (GS120) for 60 minutes daily for up to 12 months. There will be no Sham treatment group or randomization involved in this study.

Study identification

NCT ID
NCT06245031
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Not applicable
Lead sponsor
Cognito Therapeutics, Inc.
Industry
Enrollment
402 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 92 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2024 (Actual)
Primary completion
Dec 2026 (Estimated)
Completion
Mar 2027 (Estimated)
Last update posted
May 7, 2024

2024 – 2027

United States locations

U.S. sites
53
U.S. states
21
U.S. cities
51
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
CCT Research - Foothills Research Center Phoenix Arizona 85044 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Advanced Research Center, Inc Anaheim California 92805 —
ATP Clinical Research, Inc. Costa Mesa California 92626 —
Neurology Center of North Orange County Fullerton California 92835 —
Syrentis Clinical Research Santa Ana California 92705 —
Office of Elizabeth Zarate-Rowell, MD Seal Beach California 90740 —
Mile High Research Center Denver Colorado 80218 —
JEM Research Institute Atlantis Florida 33462 —
South Lake Pain Institute Clermont Florida 34711 —
Arrow Clinical Trials Daytona Beach Florida 32117 —
Brain Matters Research Delray Beach Florida 33445 —
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912 —
Charter Research - Lady Lake Lady Lake Florida 32792 —
Multi-Specialty Research Associates, Inc. Lake City Florida 23055 —
Coastal Family Medicine - Orange Park Orange Park Florida 32073 —
Emerald Coast Neurology Pensacola Florida 32504 —
Quantum Laboratories Pompano Beach Florida 33064 —
Progressive Medical Research Port Orange Florida 32127 —
Intercoastal Medical Group - Sarasota Sarasota Florida 34239 —
Suncoast Neuroscience Associates St. Petersburg Florida 33713 —
Brain Matters Research (Kane Center) Stuart Florida 34997 —
Conquest Research Winter Park Florida 32789 —
Charter Research - Winter Park Winter Park Florida 32792 —
Emory Alzheimer's Disease Research Center Atlanta Georgia 30329 —
NeuroStudies Decatur Georgia 30033 —
Great Lakes Clinical Trials- Flourish Research- Chicago Chicago Illinois 60640 —
Great Lakes Clinical Trials- Flourish Research- Gurnee Gurnee Illinois 60031 —
Northern Light Acadia Hospital Bangor Maine 04402 —
Boston Center for Memory Newton Massachusetts 02459 —
Office of Donald S. Marks, M.D., P.C. Plymouth Massachusetts 02360 —
Sisu BHR, LLC Springfield Massachusetts 01103 —
QUEST Research Institute Farmington Michigan 48334 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
Las Vegas Medical Research Las Vegas Nevada 89113 —
The Cognitive and Research Center of New Jersey Springfield New Jersey 07081 —
Neurological Associates of Albany Albany New York 12208 —
Velocity Clinical Research - Syracuse East Syracuse New York 13057 —
Mid Hudson Medical Research New Windsor New York 12553 —
Alzheimer's Memory Center - AMC Research Matthews North Carolina 28105 —
Insight Clinical Trials, LLC Beachwood Ohio 44122 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
The Clinical Trial Center Jenkintown Pennsylvania 19046 —
Prisma Health Neurology Columbia South Carolina 29203 —
Coastal Neurology Port Royal South Carolina 29935 —
University of Tennessee Medical Center Knoxville Tennessee 37920 —
North Texas Clinical Trials Fort Worth Texas 76104 —
UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases San Antonio Texas 78229 —
TRS Health Stafford Texas 77477 —
Mercury Clinical Research Sugar Land Texas 77478 —
Wasatch Clinical Research Salt Lake City Utah 84107 —
ReCogniton Health Fairfax Virginia 22031 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06245031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06245031 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →